Cancer medicines
Abemaciclib
Abemaciclib
A CDK4/6 inhibitor for selected breast cancers, with diarrhea needing particular attention.
Sources checked · Introductory guide
On this page
How it works
It inhibits CDK4 and CDK6, disrupting cell-cycle progression.[3]
Where it is used
Used in selected HR-positive, HER2-negative high-risk early or advanced breast cancers; combinations depend on the setting.[1]
Key safety points
Follow your team’s early diarrhea plan. Seek prompt advice for dehydration, fever, new breathlessness or leg swelling.[2]
Questions for your care team
- What are my diarrhea medicines, contact thresholds and blood or liver test schedules?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- NCI · Abemaciclib (opens in a new tab)
- MedlinePlus · Abemaciclib (opens in a new tab)
- NCI Drug Dictionary · Abemaciclib (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.